TP53 and gastric cancer: For example, APG-115 was a novel MDM2/p53 inhibitor, and the report showed that it could improve the radiosensitivity effects in gastric cancer cells by regulating the expression of MDM2-p53 pathway-related proteins.162 It also observed that cell apoptosis increased and cell cycle arrested after treatment of APG-115.